Centrus Energy Corp. — Q1 2015 Form 10-Q
Reporting period: Three months ended March 31, 2015. Centrus supplies low-enriched uranium (LEU) and performs American Centrifuge research and demonstration work. It had ceased enrichment at Paducah in 2013 and returned the leased site to DOE in October 2014. Centrus emerged from Chapter 11 on September 30, 2014 and adopted fresh start accounting; accordingly, Q1 2015 “Successor” results are not directly comparable with Q1 2014 “Predecessor” results.
Key financial results
| Metric | Q1 2015 | Q1 2014 |
|---|---|---|
| Revenue | $167.8 million | $148.6 million |
| Gross profit (loss) | $6.9 million | $(20.9) million |
| Gross margin | 4.1% | (14.1)% |
| Operating loss | $(11.0) million | $(39.2) million |
| Net loss | $(15.4) million | $(50.8) million |
| Basic and diluted loss per share | $(1.71) | $(10.37) |
| Operating cash flow | $2.3 million | $(229.7) million |
Revenue increased 13%. SWU revenue fell 29% to $103.6 million, while uranium revenue was $43.2 million versus none in the prior-year quarter; contract-services revenue rose to $21.0 million from $3.0 million, largely reflecting the American Centrifuge contract. SWU sales volume declined 36%, partly offset by a 12% increase in average billed SWU price. Gross profit improved principally because LEU non-production expenses fell to $4.7 million from $34.9 million and the average SWU price billed increased. Prior-year advanced technology costs included work under a DOE cooperative agreement that ended in April 2014.
Cash and cash equivalents were $225.0 million at March 31, 2015, versus $218.8 million at year-end; working capital was $363.1 million versus $366.0 million. Operating cash flow benefited from a $124.1 million decline in inventories and a $37.2 million decline in receivables, partly offset by $140.1 million paid against SWU purchase payables. Investing activities provided $3.9 million; there were no financing cash flows or capital expenditures in the quarter. Cash generation therefore reflected working-capital movements, not profitable operations.
Total assets were $1.085 billion and total liabilities were $1.079 billion. Current assets were $755.6 million and current liabilities $392.5 million. Debt was $244.0 million of 8% PIK Toggle Notes, maturing September 30, 2019; the notes’ estimated fair value was $104.0 million. The quarter’s interest payment included $6.0 million cash and $3.6 million in PIK interest. Pension benefit liabilities were $177.3 million and postretirement health and life obligations were $212.8 million.
Outlook, commentary, and material risks
- Management expected 2015 SWU deliveries of approximately 2 million, compared with approximately 3 million in 2014 and 8 million in 2013. Its 2015 guidance was $350–$375 million of SWU and uranium revenue, $425–$450 million of total revenue, and year-end cash of $175–$200 million.
- The ACTDO Agreement with UT-Battelle was extended through September 30, 2015, bringing its total price to approximately $117 million. Management cited a $100 million federal FY2016 budget request for domestic enrichment; House-passed legislation provided $50 million in direct appropriations and up to $50 million in reprogramming authority, while Senate action remained pending as of May 1, 2015. Future funding was not assured.
- Management said current LEU oversupply and SWU prices at more than decade lows made its prior commercial American Centrifuge deployment plans uneconomic under prevailing conditions. It expected commercial deployment to be delayed for several years and continued limited demobilization; approximately $5 million of additional demobilization costs was expected, primarily in Q2 2015.
- Key risks include dependence on Russian LEU purchases and the ability to sell or import those supplies; declining sales backlog and customer delivery timing; lack of commercial project financing or government support; and liquidity sensitivity to customer receipts, purchase obligations, and ACTDO funding.
- DOE disputes and claims remain unresolved. Approximately $77 million of DOE invoices were subject to filed Contract Disputes Act claims, but the recognized long-term receivable was $21.6 million because collection timing and amount were uncertain. A separate $42.8 million pension/postretirement cost claim was denied and appealed, with a full valuation allowance. Centrus also filed a $1.6 million claim concerning a disputed DOE credit.
- Potential ERISA Section 4062(e) pension exposure remained under discussion with the PBGC. The PBGC had previously estimated approximately $130 million for the Portsmouth transition, an estimate Centrus disputed. Centrus believed changes in law and plan funding could address potential Section 4062(e) liability, but the PBGC could pursue other ERISA remedies.
Most important facts for investors to verify
- Whether FY2016 appropriations or another agreement extend federal support for the American Centrifuge program beyond September 30, 2015.
- Whether actual 2015 revenue, deliveries, and ending cash meet management’s guidance, given order timing and continuing market weakness.
- Cash conversion and remaining inventory and purchase obligations, particularly whether operating cash flow depends on further working-capital reductions.
- Progress and potential recoveries in DOE claims, and any PBGC action or change in pension-related obligations.
- The terms and funding needed to extend PIK Toggle Notes maturity to 2024; absent qualifying funding conditions, the stated maturity is 2019.